MANCHESTER, England--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB & OTCQB: GTHP), developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, today announced that the LuViva™ Advanced Cervical Scan was selected for inclusion in a review of new technologies by the United Kingdom’s National Institute for Health and Clinical Excellence (NICE).
